DK658889A - Farmaceutisk praeparat til brug ved behandling af psoriasis - Google Patents

Farmaceutisk praeparat til brug ved behandling af psoriasis Download PDF

Info

Publication number
DK658889A
DK658889A DK658889A DK658889A DK658889A DK 658889 A DK658889 A DK 658889A DK 658889 A DK658889 A DK 658889A DK 658889 A DK658889 A DK 658889A DK 658889 A DK658889 A DK 658889A
Authority
DK
Denmark
Prior art keywords
psoriasis
treatment
pharmaceutical preparation
composition
excipient
Prior art date
Application number
DK658889A
Other languages
Danish (da)
English (en)
Other versions
DK658889D0 (da
Inventor
Patrick Joseph Creaven
Hiroshi Ishimaru
Kazuyoshi Hori
Original Assignee
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind filed Critical Asahi Chemical Ind
Publication of DK658889D0 publication Critical patent/DK658889D0/da
Publication of DK658889A publication Critical patent/DK658889A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DK658889A 1988-12-27 1989-12-22 Farmaceutisk praeparat til brug ved behandling af psoriasis DK658889A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29049788A 1988-12-27 1988-12-27

Publications (2)

Publication Number Publication Date
DK658889D0 DK658889D0 (da) 1989-12-22
DK658889A true DK658889A (da) 1990-06-28

Family

ID=23116275

Family Applications (1)

Application Number Title Priority Date Filing Date
DK658889A DK658889A (da) 1988-12-27 1989-12-22 Farmaceutisk praeparat til brug ved behandling af psoriasis

Country Status (7)

Country Link
EP (1) EP0377823B1 (enExample)
JP (1) JPH02209812A (enExample)
AT (1) ATE108331T1 (enExample)
AU (1) AU633037B2 (enExample)
CA (1) CA2003981C (enExample)
DE (1) DE68916777T2 (enExample)
DK (1) DK658889A (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2659235A1 (fr) * 1990-03-09 1991-09-13 Asahi Chemical Ind Application du facteur tumoral de necrose au traitement des troubles de demyelinisation, de l'uveite ou des troubles de l'hote qui a recu une greffe.
US20040220103A1 (en) 1999-04-19 2004-11-04 Immunex Corporation Soluble tumor necrosis factor receptor treatment of medical disorders
US8715664B2 (en) 2005-05-16 2014-05-06 Abbvie Biotechnology Ltd. Use of human TNFα antibodies for treatment of erosive polyarthritis
TWI439284B (zh) 2004-04-09 2014-06-01 Abbvie Biotechnology Ltd 用於治療ＴＮＦα相關失調症之多重可變劑量療法
US9605064B2 (en) 2006-04-10 2017-03-28 Abbvie Biotechnology Ltd Methods and compositions for treatment of skin disorders
CN106729633A (zh) * 2017-03-03 2017-05-31 上海唯科生物制药有限公司 一种肿瘤坏死因子直肠给药制剂及其制备方法
US20240108746A1 (en) * 2020-12-16 2024-04-04 Molecular Partners Ag Novel slow-release prodrugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
AU2844889A (en) * 1988-01-22 1989-07-27 Collagen Corporation Method for suppressing the growth of normal and cancer cells

Also Published As

Publication number Publication date
EP0377823A3 (en) 1991-09-11
EP0377823B1 (en) 1994-07-13
DE68916777T2 (de) 1995-03-16
EP0377823A2 (en) 1990-07-18
ATE108331T1 (de) 1994-07-15
AU633037B2 (en) 1993-01-21
CA2003981A1 (en) 1990-06-27
AU4685389A (en) 1990-07-05
JPH0565492B2 (enExample) 1993-09-17
CA2003981C (en) 2000-06-13
JPH02209812A (ja) 1990-08-21
DE68916777D1 (de) 1994-08-18
DK658889D0 (da) 1989-12-22

Similar Documents

Publication Publication Date Title
CA2039197A1 (en) Pharmaceutic Formulation for the Treatment of Alcoholism
CA2180535A1 (en) A method for treatment of psoriasis, by omeprazole or related compounds
ATE182786T1 (de) Pharmazeutische und/oder kosmetische zubereitung
GB9305295D0 (en) Therapeutic compounds
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
CA2178760A1 (en) HIV Protease Inhibitors
CA2041417A1 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
DK0625516T3 (da) Benzensulfonamidderivater til behandling af blæreustabilitet
CA2046069A1 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
DK658889A (da) Farmaceutisk praeparat til brug ved behandling af psoriasis
DE69400334D1 (de) Diaminsalze von clavulansäure
CA2027814A1 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
NO922136L (no) Anvendelse av gibberelliner for behandling av prostatitisog psoriasis
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
CA2030344A1 (en) Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
DE69107226D1 (de) Verwendung von Tumornekrosefaktor.
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
PT91610A (pt) Process for the preparation of compounds for the treatment of arteritis rheumatoidal
EP0429324A3 (en) Use of n-methyl-2-(3-pyridyl)2-tetrahydrothiopyran-carbothioamide-1-oxide for the preparation of medicaments for the treatment of coronary insufficiency
GR920100423A (el) Ανταγωνιστές 5-ΗΤ4 κινολιζιδινυλ εστέρος.
ATE88342T1 (de) Pharmazeutische zubereitungen zur behandlung der psoriasis, psoriatischen arthritis, neurodermitis und enteritis regionalis crohn.
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi
ITBO930460A0 (it) Procedimento per preparare forme farmaceutiche a rilascio controllato del principio attivo e le forme farmaceutiche cosi' ottenute.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment